09/23/2024 | Press release | Distributed by Public on 09/23/2024 14:11
SKILLMAN, N.J. September 23, 2024 - Kenvue Inc. (NYSE: KVUE) ("Kenvue" or the "Company"), the maker of iconic brands such as Aveeno®, Listerine®, Neutrogena® and Tylenol®, is advancing progress toward the climate change goals outlined in its Healthy Lives Mission environmental, social and governance strategy, including releasing its first Task Force on Climate-related Financial Disclosures (TCFD) report.
"Publishing our TCFD report represents an important step in our proactive approach to integrating climate considerations into our business strategy, operations, value chain and marketed products," said Pamela Gill-Alabaster, Global Head of ESG & Sustainability at Kenvue. "We have made meaningful progress, including the validation of our near-term greenhouse gas (GHG) emissions reduction targets by the Science Based Targets initiative (SBTi) and the release of our inaugural Healthy Lives Mission report in support of our ambition to help contribute to a healthier future."
Healthy Lives Mission was developed with the understanding that human health is inseparably linked to environmental health. Consumers also see this connection, with three out of four adults globally seeing a link between human health and climate change according to an online survey commissioned by Kenvue earlier this year5. The same survey revealed that 86% of people expect health-related consequences of climate change to worsen over the next 5 to 10 years.
Kenvue's climate change goals and commitments are part of the Healthy Planet pillar of its Healthy Lives Mission strategy and focus on advancing sustainability across the Company's operations - from product and packaging design to material sourcing, manufacturing and transportation. Highlights on progress as reported in the Healthy Lives Mission 2023 Report include:
Since the beginning of 2024, Kenvue has completed new onsite solar installations at its Sezanne, France, and Madra, Greece manufacturing sites, which will provide 1.75MW and 0.186MW of renewable energy, respectively. The Company also expects to complete additional onsite solar installations at its Cape Town, South Africa, Minhang, China and Jakarta, Indonesia manufacturing sites this year, further advancing progress toward its goal of 100% of its electricity usage for its operations1 being renewable4 by 203010, 11.
To address Scope 3 indirect upstream GHG emissions, Kenvue launched a Supplier Climate Action Program in July to engage purchased goods and services and upstream transportation and distribution suppliers. Through this program, the Company will help these suppliers set science-based targets of their own and work to decarbonize their operations. Kenvue has also joined the Energize program, which is designed to help suppliers learn about renewable electricity and provide sourcing opportunities, either as sole sourced or with other suppliers.
Recognizing the value of collaboration to accelerate progress within and across sectors, Kenvue is an active member of several coalitions that have focused workstreams which support climate action and the journey toward net zero including the WWF Climate Business Network and the WWF Renewable Thermal Collaborative. Most recently, Kenvue joined the Forum for the Future's Climate and Health Coalition to support the integrated transformation of human health and climate systems toward outcomes that deliver benefits for both people and planet.
To read the Kenvue Healthy Lives Mission 2023 Report, visit www.kenvue.com/hlm-report-2023. To access the full TCFD report, visit https://www.kenvue.com/task-force-on-climate-related-financial-disclosures-2023-report.
About Kenvue
Kenvue is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
Cautions Concerning Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995, including forward-looking statements related to, among other things, risks and opportunities associated with the Healthy Lives Mission, climate, forests and our related ESG estimates, projections, goals, targets, commitments and expected results. Forward-looking statements may be identified by the use of words such as "plans," "expects," "may," "will," "anticipates," "estimates," "intends," "goal," "target," "commitment," and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates.
A list and descriptions of risks, uncertainties, and other factors can be found in Kenvue's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.comor on request from Kenvue. Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.
1 Applies to all Kenvue-owned facilities where Kenvue has operational control, regardless of building type; all leased facilities used for manufacturing and/or research and development; and leased, non-manufacturing and/or non-research and development facilities where the facility is greater than 50,000 square feet and where Kenvue has operational control. The 2020 baseline and all subsequent reporting years include all facilities aligned to Kenvue's structure upon separation from Johnson & Johnson in 2023 and do not include any operational or organizational exclusions. Scope 1 are greenhouse gas (GHG) emissions that Kenvue directly generates - e.g., running boilers and vehicles using fossil fuels. Fleet emissions are reported as CO2 and do not include other greenhouse gas emissions. Scope 2 are GHG emissions that Kenvue indirectly generates - from electricity or energy purchased for heating and cooling buildings.